Ligand validation:3T5M

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3T5M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3T5M_AMP_B_801	13%	41%	0.218	0.754	0.9	1.39	1	4	1	0	100%	0.89
3T5M_AMP_A_801	8%	42%	0.225	0.695	0.88	1.37	1	4	1	0	100%	0.86
5K99_AMP_D_101	99%	36%	0.05	0.988	1.13	1.4	2	1	0	0	100%	0.9278
3U1B_AMP_A_401	79%	35%	0.098	0.943	0.89	1.65	-	6	1	0	100%	1
3TYX_AMP_B_401	26%	17%	0.23	0.87	1.52	2.06	5	6	2	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.